RT Journal Article SR Electronic T1 Treatment options for apnoea of prematurity JF Archives of Disease in Childhood - Fetal and Neonatal Edition JO Arch Dis Child Fetal Neonatal Ed FD BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health SP F352 OP F356 DO 10.1136/archdischild-2015-310228 VO 101 IS 4 A1 Sarah U Morton A1 Vincent C Smith YR 2016 UL http://fn.bmj.com/content/101/4/F352.abstract AB Apnoea of prematurity (AOP) affects almost all infants born at <28 weeks gestation or with birth weight <1000 g. When untreated, AOP may be associated with negative outcomes. Because of these negative outcomes, effective treatment for AOP is an important part of optimising care of preterm infants. Standard treatment usually involves xanthine therapy and respiratory support. Cutting-edge work with stochastic vibrotactile stimulation and new pharmaceutical agents continues to expand therapeutic options. In this article, we review the pathophysiology of AOP, associated conditions and treatment options.